{
    "medicine_id": "14b3fe318e8bbeb30a57f80bd125dbc8095ccfbc",
    "platform_id": "10945",
    "metadata": {
        "name": "Atazanavir Sandoz 200 mg capsule hard",
        "composition": "Each hard capsule contains 200 mg of atazanavir as sulfate",
        "clinical_particulars": {
            "therapeutic_indications": "Atazanavir capsules co administered with low dose ritonavir are indicated for the treatment of HIV 1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products see section 4 2 Based on available virological and clinical data from adult patients no benefit is expected in patients with strains resistant to multiple protease inhibitors 4 PI mutations The choice of Atazanavir in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patient s treatment history see sections 4 4 and 5 1",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1 Atazanavir is contraindicated in patients with severe hepatic insufficiency see sections 4 2 4 4 and 5 2 Atazanavir with ritonavir is contraindicated in patients with moderate hepatic insufficiency see sections 4 2 4 4 and 5 2 Co administration with simvastatin or lovastatin see section 4 5 Combination of rifampicin see section 4 5 Combination of the PDE5 inhibitor sildenafil when used for the treatment of pulmonary arterial hypertension PAH only see section 4 5 For co administration of sildenafil for the treatment of erectile dysfunction see sections 4 4 and 4 5 Co administration with medicinal products that are substrates of the CYP3A4 isoform of cytochrome P450 and have narrow therapeutic windows e g quetiapine lurasidone alfuzosin astemizole terfenadine cisapride pimozide quinidine bepridil triazolam midazolam administered orally for caution on parenterally administered midazolam see section 4 5 lomitapide and ergot alkaloids particularly ergotamine dihydroergotamine ergonovine methylergonovine see section 4 5 Co administration with grazoprevir containing products including elbasvir grazoprevir fixed dose combination see section 4 5 Co administration with glecaprevir pibrentasvir fixed dose combination see section 4 5 Co administration with products containing St John s wort Hypericum perforatum see section 4 5",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Lactose monohydrate;Crospovidone (type A) (E 1202);Silica, colloidal anhydrous (E 551);Magnesium stearate (E 470b);Gelatin;Titanium dioxide (E 171);Indigotine (E 132) (contains sodium);Printing ink, white:;Shellac;Titanium dioxide (E 171);Propylene glycol (E 1520)",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2021-07-06"
    }
}